Skip to content

GE Healthcare VolumeRAD Lung Nodule Detection Study

GE Healthcare VolumeRAD Lung Nodule Detection Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00963651
Enrollment
187
Registered
2009-08-21
Start date
2009-08-31
Completion date
2013-07-31
Last updated
2013-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Pulmonary Nodules, Pulmonary Nodule, Solitary

Keywords

Pulmonary nodule, solitary, Multiple pulmonary nodules

Brief summary

To perform a multiple reader, multiple case (MRMC) observer study assessing the detection performance of VolumeRAD tomosynthesis of the chest in detecting lung nodules.

Detailed description

Digital tomosynthesis is a form of limited angle tomography that creates a series of section images using a conventional x-ray tube and generator, a digital detector, and appropriate reconstruction software. It creates section images from a series of projection images acquired as the x-ray tube moves along a prescribed path. Because tomosynthesis can minimize the visual presence of overlying anatomy - the ribs, for example - it has the potential to improve the detection of lesions such as pulmonary nodules when compared with conventional chest radiography. The primary aim of this study is to determine whether the use of VolumeRAD tomosynthesis, in addition to CxR, increases physician accuracy in the detection of lung nodules between 3mm and 20mm in diameter when compared to conventional posterior-anterior (PA) and lateral (LAT) chest radiography (CxR). This aim will be addressed by measuring free-response performance of experienced (with VolumeRAD), blinded expert readers' detection performance. Specifically, we will compare detection performance, as measured by the area under the alternative free response receiver operating characteristic (AFROC) curve, among readers viewing PA and LAT chest X-rays versus VolumeRAD tomosynthesis. The nodule will be the unit of analysis.

Interventions

DEVICEChest tomosynthesis and X-ray

VolumeRAD tomosynthesis; Conventional Chest X-ray; Dual energy (bone and soft tissue PA chest images)

Sponsors

American College of Radiology - Image Metrix
Lead SponsorINDUSTRY
GE Healthcare
CollaboratorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Scheduled for chest CT as part of their needed medical care; * If available, individuals who have had previous imaging to suggest they fulfill the needs of the study; * 18 years of age, or older; * In good enough physical condition to stand motionless and hold their breath during the image acquisition procedures.

Exclusion criteria

* Children under 18 years of age; * Women who are pregnant or who suspect they may be pregnant; * Individuals who on previous imaging are shown to have objects in or around the lungs that might produce substantial artifacts that would obscure pulmonary nodules; * Individuals who on recent imaging had active lung or pleural disease that would obscure pulmonary nodules; * Individuals with more than 5 pulmonary nodules between 5mm and 20mm in diameter in either right or left lung. * Individuals suspected to have more than 15 total nodules between 3mm and 20mm. NOTE that up to 20 nodules between 3mm and 20mm will be allowed in the final study sample.

Design outcomes

Primary

MeasureTime frameDescription
Multi-reader, multi-case Receiver Operating Characteristics (ROC) methodology.Post accrual of 210 participantsThe primary objective of this study is to determine if the use of VolumeRAD tomosynthesis increases the accuracy of the detection of lung nodules between 3mm and 20mm in diameter when compared to conventional PA and lateral chest radiography alone.

Secondary

MeasureTime frame
Actionability classification accuracy of all modalitiesMultipe reader, multiple case reader study

Countries

Sweden, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026